A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
RAMSAY GENERALE DE SANTE operates in the Medical - Care Facilities industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 5.9B | 5.9B | 5.4B | 5.1B | 4.5B | 4.7B |
| Net Income | -61M | -61M | -58M | 69M | 135M | 87M |
| EPS | $-0.55 | $-0.55 | $-0.53 | $0.49 | $1.13 | $0.70 |
| Free Cash Flow | 785M | 785M | 634M | 650M | 276M | 770M |
| ROIC | 17.6% | 4.8% | 3.0% | 3.6% | 4.3% | 4.2% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 1.66 | 1.66 | 3.28 | 3.28 | 3.67 |
| Dividends/Share | $0.15 | $0.00 | $0.13 | $0.00 | $0.00 | $0.05 |
| Operating Income | 196M | 196M | 174M | 261M | 307M | 296M |
| Operating Margin | 3.3% | 3.3% | 3.2% | 5.1% | 6.8% | 6.2% |
| ROE | -4.7% | -4.7% | -4.4% | 5.2% | 10.3% | 6.7% |
| Shares Outstanding | 110M | 110M | 110M | 142M | 119M | 125M |
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 4.7B | 4.5B | 5.1B | 5.4B | 5.9B | 5.9B |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 296M | 307M | 261M | 174M | 196M | 196M |
| Op. Margin | 6.2% | 6.8% | 5.1% | 3.2% | 3.3% | 3.3% |
| Net Income | 87M | 135M | 69M | -58M | -61M | -61M |
| Net Margin | 1.8% | 3.0% | 1.4% | -1.1% | -1.0% | -1.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 4.2% | 4.3% | 3.6% | 3.0% | 4.8% | 17.6% |
| ROE | 6.7% | 10.3% | 5.2% | -4.4% | -4.7% | -4.7% |
| ROA | 1.1% | 1.8% | 0.9% | -0.8% | -0.8% | -0.8% |
| Cash Flow | ||||||
| Op. Cash Flow | 770M | 276M | 650M | 634M | 785M | 785M |
| Free Cash Flow | 770M | 276M | 650M | 634M | 785M | 785M |
| Owner Earnings | 331M | -121M | 212M | 173M | 294M | 294M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 439M | 397M | 438M | 461M | 491M | 491M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 439M | 397M | 438M | 461M | 491M | 491M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 5.9M | 13M | 12M | 14M | 16M | 16M |
| Dividend Yield | 0.2% | 0.5% | 0.4% | 0.8% | 1.3% | 1.4% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 1.9B | 118M | 16M | 61M | 168M | 168M |
| Balance Sheet | ||||||
| Net Debt | 4.0B | 4.1B | 4.2B | 1.8B | 1.7B | -415M |
| Cash & Equiv. | 718M | 140M | 382M | 388M | 415M | 415M |
| Long-Term Debt | N/A | N/A | N/A | 2.0B | 2.1B | 2.1B |
| Debt/Equity | 3.67 | 3.28 | 3.28 | 1.66 | 1.66 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 1.3B | 1.3B | 1.4B | 1.3B | 1.3B | 1.3B |
| Total Assets | 7.9B | 7.1B | 7.6B | 7.4B | 7.7B | 7.7B |
| Total Liabilities | 6.6B | 5.8B | 6.2B | 6.2B | 6.4B | 6.4B |
| Intangibles | N/A | N/A | N/A | 226M | 233M | 233M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital | -97M | -242M | -137M | -237M | N/A | N/A |
| Current Assets | 1.7B | 1.3B | 1.5B | 1.6B | N/A | N/A |
| Current Liabilities | 1.8B | 1.6B | 1.6B | 1.8B | N/A | N/A |
| Per Share Data | ||||||
| EPS | 0.70 | 1.13 | 0.49 | -0.53 | -0.55 | -0.55 |
| Owner EPS | 2.65 | -1.01 | 1.50 | 1.57 | 2.66 | 2.66 |
| Book Value | 10.36 | 10.92 | 9.76 | 11.73 | 11.74 | 11.74 |
| Cash Flow/Share | 6.15 | 2.31 | 4.58 | 5.76 | 7.11 | 3.90 |
| Dividends/Share | 0.05 | 0.00 | 0.00 | 0.13 | 0.00 | 0.15 |
| Shares Out. | 125.1M | 119.4M | 142.0M | 110.0M | 110.4M | 110.4M |
| Valuation | ||||||
| P/E Ratio | 35.5 | 17.3 | 43.0 | -23.1 | -18.7 | -18.6 |
| P/FCF | 4.0 | 8.4 | 4.6 | 2.1 | 1.5 | 1.4 |
| EV/EBIT | 24.1 | 21.1 | 27.4 | 17.9 | 14.7 | 3.7 |
| Price/Book | 2.4 | 1.8 | 2.2 | 1.0 | 0.9 | 0.9 |
| Price/Sales | 0.7 | 0.5 | 0.6 | 0.2 | 0.2 | 0.2 |
| FCF Yield | 24.9% | 11.9% | 21.8% | 47.1% | 68.6% | 69.1% |
| Market Cap | 3.1B | 2.3B | 3.0B | 1.3B | 1.1B | 1.1B |
| Avg. Price | 23.17 | 22.73 | 21.69 | 15.86 | 11.44 | 10.30 |
| Year-End Price | 24.69 | 19.53 | 21.01 | 12.23 | 10.36 | 10.30 |
RAMSAY GENERALE DE SANTE passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 1.4x vs a median of 4.0x. The company's 5-year average ROIC is 4.0%. Total shareholder yield (dividends) is 1.4%. At current prices, the estimated annualized return to fair value is -3.2%.
RAMSAY GENERALE DE SANTE (GDS-PA) has a 5-year average return on invested capital (ROIC) of 4.0%. This is below average and may indicate limited pricing power.
RAMSAY GENERALE DE SANTE (GDS-PA) has a market capitalization of $1.1B. It is classified as a small-cap stock.
Yes, RAMSAY GENERALE DE SANTE (GDS-PA) pays a dividend with a trailing twelve-month yield of 1.43%.
RAMSAY GENERALE DE SANTE (GDS-PA) operates in the Medical - Care Facilities industry, within the Healthcare sector.
RAMSAY GENERALE DE SANTE (GDS-PA) reported annual revenue of $5.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
RAMSAY GENERALE DE SANTE (GDS-PA) has a net profit margin of -1.0%. The company is currently unprofitable.
RAMSAY GENERALE DE SANTE (GDS-PA) generated $785 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
RAMSAY GENERALE DE SANTE (GDS-PA) has a debt-to-equity ratio of 1.66. This indicates higher leverage, which may increase financial risk.
RAMSAY GENERALE DE SANTE (GDS-PA) reported earnings per share (EPS) of $-0.55 in its most recent fiscal year.
RAMSAY GENERALE DE SANTE (GDS-PA) has a return on equity (ROE) of -4.7%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 5 years of financial data for RAMSAY GENERALE DE SANTE (GDS-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
RAMSAY GENERALE DE SANTE (GDS-PA) has a book value per share of $11.74, based on its most recent annual SEC filing.